查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1822385

消化二胺氧化酶補充劑市場預測（至2032年）：按劑型、來源、產品成分、通路、應用和地區進行的全球分析

Digestive Diamine Oxidase Enzyme Supplements Market Forecasts to 2032 - Global Analysis By Dosage Form (Capsules, Tablets, Powder, Liquid, and Other Dosage Forms), Source, Product Composition, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球消化二胺氧化酶補充劑市場預計在 2025 年達到 3,200 萬美元，到 2032 年將達到 5,000 萬美元，預測期內的複合年成長率為 7.6%。

消化二胺氧化酶 (DAO) 補充劑是專為組織胺不耐受患者設計的膳食補充劑。 DAO 是一種天然酶，存在於消化道中，負責分解食物中過量的組織胺。對於 DAO 活性降低的個體，組織胺積聚會導致頭痛、消化器官系統問題和皮膚反應等症狀。 DAO 補充劑可提供這種酵素的額外來源，改善組織胺代謝，增強消化舒適度，並支持整體腸道健康。

組織胺不耐受增加

隨著越來越多的人出現偏頭痛、胃腸道疾病和皮膚反應等症狀，對有針對性的消化器官系統支持的需求日益成長。醫療保健提供者認知到DAO缺乏會導致慢性炎症，從而引起了越來越多的臨床關注。酶穩定性和生物利用度方面的技術進步正在提高補充劑的有效性。個人化營養趨勢也越來越受到消費者的青睞，他們正在尋求針對組織胺相關問題的客製化解決方案。由於診斷手段的改善和健康意識的增強，新興市場的需求正在激增。

有限的臨床研究

監管機構要求提供可靠的療效數據，這延遲了產品核准，並限制了治療聲明。規模較小的製造商難以資助隨機試驗，這為進入市場和創新設置了障礙。 DAO 與機能性食品和膳食補充劑的整合使監管途徑更加複雜。缺乏標準化的組織胺不耐受檢測通訊協定，進一步加劇了臨床應用的複雜性。這些限制阻礙了主流醫療機構的核准，並限制了基於 DAO 的干涉措施的保險覆蓋範圍。

電子商務和網上零售的成長

消費者擴大選擇在線購買保健產品，這主要受到便利性、產品多樣性以及小眾配方的吸引。訂閱模式和定向廣告正在提升品牌知名度和客戶維繫。包裝和低溫運輸物流的創新正在提升貨架穩定性和全球影響力。線上評論和網紅行銷正在塑造消費者偏好，並加速產品試用。隨著數位健康生態系統的發展，電子商務正成為補充劑探索和教育的重要管道。

來自替代療法的競爭

許多消費者選擇改變生活方式和非處方藥，因為它們熟悉且價格低廉。機能性食品和草藥作為天然替代品也越來越受歡迎。組織胺不耐受缺乏通用的診斷標準，導致治療方法碎片化。針對腸道滲透性和免疫調節的新興生物技術解決方案可能會分散人們對基於DAO的產品的注意力。如果沒有明確的差異化和臨床支持，DAO補充劑可能會在競爭激烈的消化器官系統健康領域中黯然失色。

COVID-19的影響

疫情擾亂了供應鏈，推遲了產品發布，並影響了DAO補充劑的供應。封鎖和醫療保健優先順序的調整導致非必要診斷減少，並推遲了組織胺不耐受的檢測。然而，這場危機加速了消費者對免疫和腸道健康的興趣，間接推動了對DAO酶的興趣。數位健康諮詢和遠距營養平台擴大了獲得個人化補充劑建議的管道。後疫情時代的策略如今強調韌性、直銷管道以及與更廣泛的健康生態系統的整合。

預計膠囊市場在預測期內將佔據最大佔有率

膠囊市場預計將在預測期內佔據最大市場佔有率，這得益於其便利性、劑量準確性和消費者熟悉度。封裝技術正在提高酶的穩定性，並使其在胃腸道中實現靶向釋放。製造商正在開發純素膠囊和無過敏原配方，以擴大其吸引力。與液體和粉末形式相比，膠囊具有更長的保存期限和更易攜帶的特性。與電商包裝和訂閱模式的兼容性提高了分銷效率。隨著對謹慎易用的補充劑的需求日益成長，膠囊仍然是各個人群的首選形式。

預計醫院和診所部門在預測期內將見證最高的複合年成長率。

由於臨床上對組織胺不耐受的認知不斷提高，預計醫院和診所細分市場將在預測期內實現最高成長率。胃腸病學和過敏科室整合DAO檢測正在擴大其治療用途。越來越多的醫生推薦DAO酶作為飲食干預和藥物治療的輔助手段。報銷框架和臨床指南的改進正在推動機構採購量的增加。用於住院護理和術後恢復的複合配方DAO產品已成為新興趨勢。隨著診斷準確性的提高，醫院和診所可能在DAO補充的主流化中發揮關鍵作用。

佔比最大的地區：

受健康意識增強和中產階級規模擴大的推動，亞太地區預計將在預測期內佔據最大的市場佔有率。由於飲食習慣和都市區生活方式的改變，中國、印度和日本等國家對消化器官系統健康產品的接受度正在上升。政府推廣膳食補充劑和機能性食品的措施正在支持市場擴張。本地製造商正在投資酶研究和區域分銷網路。電子商務和行動健康平台的興起正在加速消費者獲得DAO補充劑的管道。全球品牌與區域公司之間的策略合作夥伴關係正在增強產品在地化和市場覆蓋率。

複合年成長率最高的地區：

在預測期內，北美地區預計將呈現最高的複合年成長率，這得益於技術創新和消費者對腸道健康解決方案的強勁需求。美國和加拿大在DAO研究方面處於領先地位，新興企業和學術機構正在探索新的給藥系統和配方。監管機構正在簡化膳食補充劑的通路，以加快產品進入市場的速度。食物過敏和慢性消化系統疾病的高發性正推動臨床對DAO酶的興趣。數位健康平台和個人化營養應用程式正在提高消費者的參與度和依從性。人們對組織胺不耐受的認知日益加深，這促使北美在DAO補充劑的創新和應用方面引領潮流。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球消化二胺氧化酶補充劑市場（按劑型）

  • 膠囊
  • 藥片
  • 粉末
  • 液體
  • 其他劑型

6. 全球消化二胺氧化酶補充劑市場（依來源）

  • 動物源性
  • 植物來源
  • 微生物/發酵

7. 全球消化二胺氧化酶補充劑市場（依產品成分）

  • 單一酵素製劑
  • 酵素+營養補充品混合物

8. 全球消化二胺氧化酶補充劑市場（按通路）

  • 網上零售/電子商務
  • 醫院和診所
  • 藥局和藥局
  • 健康食品和專賣店
  • 其他通路

9. 全球消化二胺氧化酶補充劑市場（按應用）

  • 非處方補充劑
  • 功能性食品和飲料
  • 臨床/醫療保健應用
  • 其他用途

10. 全球消化二胺氧化酶補充劑市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Biogena Group
  • Nature's Way
  • Enzymedica, Inc.
  • Jarrow Formulas, Inc.
  • Intoleran
  • NOW Foods
  • Klaire Labs
  • Gaia Herbs
  • NATURDAO
  • Himalaya Herbal Healthcare
  • Pure Encapsulations
  • NUTRALife
  • Seeking Health
  • XYMOGEN
  • Swanson Health Products
Product Code: SMRC31139

According to Stratistics MRC, the Global Digestive Diamine Oxidase Enzyme Supplements Market is accounted for $0.032 billion in 2025 and is expected to reach $0.05 billion by 2032 growing at a CAGR of 7.6% during the forecast period. Digestive Diamine Oxidase (DAO) enzyme supplements are dietary products designed to support individuals with histamine intolerance. DAO is a natural enzyme in the digestive tract responsible for breaking down excess histamine from foods. In people with reduced DAO activity, histamine can accumulate, causing symptoms like headaches, digestive issues, or skin reactions. DAO supplements provide an additional source of this enzyme, helping improve histamine metabolism, enhance digestive comfort, and support overall gut health.

Market Dynamics:

Driver:

Rising prevalence of histamine intolerance

As more individuals experience symptoms like migraines, gastrointestinal distress, and skin reactions, the need for targeted digestive support is rising. Healthcare providers are recognizing DAO deficiency as a contributing factor to chronic inflammatory conditions, prompting wider clinical interest. Technological advancements in enzyme stabilization and bioavailability are enhancing supplement efficacy. The trend toward personalized nutrition is also driving adoption, with consumers seeking tailored solutions for histamine-related issues. Emerging markets are witnessing a surge in demand due to improved diagnostic access and rising health consciousness.

Restraint:

Limited Clinical Research

Regulatory bodies require robust efficacy data, which slows product approvals and limits therapeutic claims. Smaller manufacturers struggle to fund randomized trials, creating barriers to entry and innovation. The integration of DAO into functional foods and nutraceuticals adds complexity to regulatory pathways. Lack of standardized testing protocols for histamine intolerance further complicates clinical adoption. These constraints hinder mainstream medical endorsement and restrict insurance coverage for DAO-based interventions.

Opportunity:

Growing E-commerce and online retail

Consumers are increasingly purchasing health products online, drawn by convenience, product variety, and access to niche formulations. Subscription models and targeted advertising are boosting brand visibility and customer retention. Innovations in packaging and cold-chain logistics are improving shelf stability and global reach. Online reviews and influencer marketing are shaping consumer preferences and accelerating product trials. As digital health ecosystems evolve, e-commerce is becoming a vital channel for supplement discovery and education.

Threat:

Competition from alternative treatments

Many consumers opt for lifestyle modifications or over-the-counter medications due to familiarity and lower cost. Functional foods and herbal remedies are also gaining traction as natural alternatives. The lack of universal diagnostic criteria for histamine intolerance leads to fragmented treatment approaches. Emerging biotech solutions targeting gut permeability and immune modulation may divert attention from DAO-based products. Without clear differentiation and clinical backing, DAO supplements risk being overshadowed in a crowded digestive health landscape.

Covid-19 Impact

The pandemic disrupted supply chains and delayed product launches, impacting availability of DAO supplements. Lockdowns and healthcare reprioritization reduced non-essential diagnostics, slowing histamine intolerance detection. However, the crisis accelerated consumer focus on immunity and gut health, indirectly boosting interest in DAO enzymes. Digital health consultations and tele-nutrition platforms expanded access to personalized supplement advice. Post-Covid strategies now emphasize resilience, direct-to-consumer channels, and integration with broader wellness ecosystems.

The capsules segment is expected to be the largest during the forecast period

The capsules segment is expected to account for the largest market share during the forecast period, due to its convenience, dosage precision, and consumer familiarity. Encapsulation technologies are improving enzyme stability and targeted release in the gastrointestinal tract. Manufacturers are innovating with vegan capsules and allergen-free formulations to broaden appeal. Capsules offer better shelf life and portability compared to liquid or powder formats. Their compatibility with e-commerce packaging and subscription models enhances distribution efficiency. As demand for discreet and easy-to-use supplements grows, capsules remain the preferred format across demographics.

The hospitals & clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & clinics segment is predicted to witness the highest growth rate, driven by rising clinical recognition of histamine intolerance. Integration of DAO testing into gastroenterology and allergy departments is expanding therapeutic use. Physicians are increasingly recommending DAO enzymes as adjuncts to dietary interventions and pharmacological treatments. Institutional procurement is rising, supported by improved reimbursement frameworks and clinical guidelines. Emerging trends include co-formulated DAO products for inpatient care and post-operative recovery. As diagnostic precision improves, hospitals and clinics will play a pivotal role in mainstreaming DAO supplementation.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share propelled by rising health awareness and expanding middle-class populations. Countries like China, India, and Japan are witnessing increased adoption of digestive health products due to changing diets and urban lifestyles. Government initiatives promoting nutraceuticals and functional foods are supporting market expansion. Local manufacturers are investing in enzyme research and regional distribution networks. E-commerce penetration and mobile health platforms are accelerating consumer access to DAO supplements. Strategic collaborations between global brands and regional players are enhancing product localization and market reach.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by technological innovation and strong consumer demand for gut health solutions. The U.S. and Canada are leading in DAO research, with startups and academic institutions exploring novel delivery systems and formulations. Regulatory agencies are streamlining pathways for dietary supplements, encouraging faster market entry. High prevalence of food sensitivities and chronic digestive disorders is boosting clinical interest in DAO enzymes. Digital health platforms and personalized nutrition apps are enhancing consumer engagement and adherence. As awareness of histamine intolerance grows, North America is setting the pace for DAO supplement innovation and adoption.

Key players in the market

Some of the key players profiled in the Digestive Diamine Oxidase Enzyme Supplements Market include Biogena Group, Nature's Way, Enzymedica, Inc., Jarrow Formulas, Inc., Intoleran, NOW Foods, Klaire Labs, Gaia Herbs, NATURDAO, Himalaya Herbal Healthcare, Pure Encapsulations, NUTRALife, Seeking Health, XYMOGEN, and Swanson Health Products.

Key Developments:

In January 2024, Swanson Health announces the launch of its brand refresh, celebrating its midwestern roots and values. The refresh encompasses a new voice and visual identity for the company, who are doubling down on their home-grown, authentic perspective - more important than ever within an industry increasingly known for its endless options and dubious claims.

In June 2020, Enzymedica(R) announced its new Kiwi Regularity chewable is now available. Each bottle contains more than 15 whole organic Zespri kiwifruits from Te Puke, New Zealand, the kiwi capital of the world. Due to their location, Zespri kiwis are known for having higher level of exposure to UV light causing the plants to form more beneficial secondary metabolites, such as polyphenols and carotenoids.

Dosage Forms Covered:

  • Capsules
  • Tablets
  • Powder
  • Liquid
  • Other Dosage Forms

Sources Covered:

  • Animal-Derived
  • Plant-Derived
  • Microbial/Fermented

Product Compositions Covered:

  • Single-Enzyme Formulations
  • Enzyme + Nutraceutical Blends

Distribution Channels Covered:

  • Online Retail/E-Commerce
  • Hospitals & Clinics
  • Pharmacies & Drug Stores
  • Health & Specialty Stores
  • Other Distribution Channels

Applications Covered:

  • Over-the-Counter Supplements
  • Functional Food & Beverage
  • Clinical/Healthcare Use
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digestive Diamine Oxidase Enzyme Supplements Market, By Dosage Form

  • 5.1 Introduction
  • 5.2 Capsules
  • 5.3 Tablets
  • 5.4 Powder
  • 5.5 Liquid
  • 5.6 Other Dosage Forms

6 Global Digestive Diamine Oxidase Enzyme Supplements Market, By Source

  • 6.1 Introduction
  • 6.2 Animal-Derived
  • 6.3 Plant-Derived
  • 6.4 Microbial/Fermented

7 Global Digestive Diamine Oxidase Enzyme Supplements Market, By Product Composition

  • 7.1 Introduction
  • 7.2 Single-Enzyme Formulations
  • 7.3 Enzyme + Nutraceutical Blends

8 Global Digestive Diamine Oxidase Enzyme Supplements Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Online Retail/E-Commerce
  • 8.3 Hospitals & Clinics
  • 8.4 Pharmacies & Drug Stores
  • 8.5 Health & Specialty Stores
  • 8.6 Other Distribution Channels

9 Global Digestive Diamine Oxidase Enzyme Supplements Market, By Application

  • 9.1 Introduction
  • 9.2 Over-the-Counter Supplements
  • 9.3 Functional Food & Beverage
  • 9.4 Clinical/Healthcare Use
  • 9.5 Other Applications

10 Global Digestive Diamine Oxidase Enzyme Supplements Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Biogena Group
  • 12.2 Nature's Way
  • 12.3 Enzymedica, Inc.
  • 12.4 Jarrow Formulas, Inc.
  • 12.5 Intoleran
  • 12.6 NOW Foods
  • 12.7 Klaire Labs
  • 12.8 Gaia Herbs
  • 12.9 NATURDAO
  • 12.10 Himalaya Herbal Healthcare
  • 12.11 Pure Encapsulations
  • 12.12 NUTRALife
  • 12.13 Seeking Health
  • 12.14 XYMOGEN
  • 12.15 Swanson Health Products

List of Tables

  • Table 1 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Dosage Form (2024-2032) ($MN)
  • Table 3 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 4 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Tablets (2024-2032) ($MN)
  • Table 5 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Powder (2024-2032) ($MN)
  • Table 6 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 7 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Other Dosage Forms (2024-2032) ($MN)
  • Table 8 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Source (2024-2032) ($MN)
  • Table 9 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Animal-Derived (2024-2032) ($MN)
  • Table 10 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Plant-Derived (2024-2032) ($MN)
  • Table 11 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Microbial/Fermented (2024-2032) ($MN)
  • Table 12 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Product Composition (2024-2032) ($MN)
  • Table 13 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Single-Enzyme Formulations (2024-2032) ($MN)
  • Table 14 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Enzyme + Nutraceutical Blends (2024-2032) ($MN)
  • Table 15 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 16 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Online Retail/E-Commerce (2024-2032) ($MN)
  • Table 17 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 18 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 19 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Health & Specialty Stores (2024-2032) ($MN)
  • Table 20 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 21 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Application (2024-2032) ($MN)
  • Table 22 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Over-the-Counter Supplements (2024-2032) ($MN)
  • Table 23 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Functional Food & Beverage (2024-2032) ($MN)
  • Table 24 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Clinical/Healthcare Use (2024-2032) ($MN)
  • Table 25 Global Digestive Diamine Oxidase Enzyme Supplements Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.